Connie Law, PharmD

Connie Law, PharmD

Connie Law, PharmD, is a Residency Preceptor with the Pharmacy Residency Program and a Clinical Pharmacy Specialist in Drug Information and Policy Development.

Areas of Expertise: Anticoagulation, Process Improvement
Locations: Main Campus

Background

Dr. Law is also involved in Anticoagulation Monitoring Program and Drug Use Evaluation committee at CHOP. She completed training in LEAN, SIX SIGMA, and CHOP Improvement Leadership program. She actively participates in various process improvement and cost savings initiatives.

Areas of Interest

Anticoagulation

LEAN and SIX SIGMA

Pharmacoeconomics

Pharmacoinformatics

Education and Training

Residency

Pharmacy Practice (PGY1) - The Philadelphia Veterans Affair Medical Center, Philadelphia, PA
Drug Information Specialty (PGY2) - Thomas Jefferson University Hospital, Philadelphia, PA

Graduate Degree

Doctor of Pharmacy - University of the Sciences in Philadelphia (USIP), Philadelphia, PA

Titles and Academic Titles

Residency Preceptor, Pharmacy Residency Program

Clinical Pharmacy Specialist in Drug Information and Policy Development

Departments and Services

Research Interests

Statin therapy in HCV
Non-formulary medication management

Publications

Papers

2015

Law C, Raffini. A guide to the use of anticoagulant drugs in children. Paediatr Drugs. 2015;17(2):105-14.

2014

Greene LA, Law C, Jung M, Walton S, Ignjatovic V, Monagle P, Raffini LJ. Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children. J Thromb Haemost 2014;12(9):1554-7.

McIntyre C, Law C, Erush S. Drug information skills: An abandoned necessity? AJHP 2014;71(11):900-1.

Posters and Presentations

2015

Bustin, A, Gomes J, Law C. Drug use evaluation of anakinra in a pediatric population. Poster presented at the 50th (2015) ASHP Midyear Clinical Meeting & Exhibition, New Orleans, LA.

Ciaramitaro J, Gomes J, Law C. Therapeutic substitution at a pediatric institution: an evaluation. Poster presented at the 50th (2015) ASHP Midyear Clinical Meeting & Exhibition, New Orleans, LA.

Hoffman M, Gomes J, Law C. Safety and formulary compliance with parenteral hydantoin anticonvulsant agents in pediatric patients. Poster presented at the 50th (2015) ASHP Midyear Clinical Meeting & Exhibition, New Orleans, LA.

2013

Greene LA, Law C, Jung M, Walton S, Raffini LJ. Lack of Anti-Xa Assay Standardization Results in Significant Dose Variation in Neonates and Children Receiving Enoxaparin. Poster presented at the 55th (2013) American Society of Hematology Annual Meeting and Exposition, New Orleans, LA.

2012

Hummel K, Law C, Le KM, Erush SC.  Standardizing the necessity for off-label informed consent: A pediatric undertaking. Poster presented at the 47th (2012) ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV.

Gembarski J, Law C. Dexmedetomidine use in a pediatric population. Poster presented at the 47th (2012) ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV.

Isaacs L, Law C. Safety of the use of isoflurane in the pediatric intensive care unit. Poster presented at the 47th (2012) ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV.

2011

Ravi S, Law C. Review of Sedation Medication-Related Respiratory Adverse Drug Events at a Pediatric Institution. Poster presented at the 46th (2011) ASHP Midyear Clinical Meeting & Exhibition, Anaheim, CA.

Leadership and Memberships

Memberships in professional organizations

American College of Clinical Pharmacy (ACCP)

American Society of Health-System Pharmacists (ASHP)

Mid-Atlantic College of Clinical Pharmacy (MACCP)